Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSIPAL: Paliperidone Palmitate vs Oral Antipsychotics in Schizophrenia
NCT01081769Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2010
- Primary completion
- Feb 2013
- Modality
- Metabolically Activated Prodrugs
- Countries
- 25
01
Overview
A Phase 3 trial of paliperidone palmitate in schizophrenia, sponsored by Janssen Pharmaceutical. Started Feb 2010; status: completed.
02
Drugs
paliperidone palmitate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01081769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081769.